Rick Stearns Will Present "An Overview of FDA's Abbreviated New Drug Application (ANDA) Requirements"

Rick Stearns will present "An Overview of FDA's Abbreviated New Drug Application (ANDA) Requirements" at the 2016 Sino-American Professionals Association (SAPA) Conference: Regulatory Reform to Support Sustained Growth" on September 17. Ricks's presentation is part of a session "Generic Drugs, FDA Inspections and Enforcement Actions - Trends and Strategies for Compliance." To learn more, click here.